Effects of a ketamine metabolite on synaptic NMDAR function
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AP5 (50 μM) and ketamine (50 μM) produced a 90-100% reduction in charge transfer indicating that AP5 and ketamine are more potent at inhibiting NMDAR-mEPSCs relative to (2R,6R)-HNK.”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Suzuki et al., 2017
In the citing paper
“NMDAR-mEPSCs were concentration-dependently and rapidly (within 10 minutes) attenuated by (2R,6R)-HNK with 10 μM having no effect and 50 μM producing an ~40% reduction in charge transfer.”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Suzuki et al., 2017
In the citing paper
“At the synaptic level, eEF2K inhibition increases AMPAR-mediated miniature EPSC amplitudes and induces rapid synaptic scaling, closely matching the profile seen after ketamine or 2R,6R-HNK [146,149,150].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [150]
In the citing paper
“Suzuki et al. (2017) 129 recently confirmed that (2R,6R)-HNK does not functionally inhibit NMDAR-mEPSCs at 10 μM 129.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [129]
In the citing paper
“These authors also reported that at a higher concentration (50 μM), (2R,6R)-HNK induces a modest (~40%) inhibition of NMDAR-mEPSCs 129, which could result in off-target effects of this metabolite at high doses.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [129]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Self-citationNMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Singh, J. B., Fedgchin, M., Daly, E., Xi, L., Melman, C., De Bruecker, G., Tadic, A., Sienaert, P., Wiegand, F., Manji, H., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.018 · Cited by 466
THE ROUTE OF ABSORPTION OF INTRAPERITONEALLY ADMINISTERED COMPOUNDS
LUKAS, G., BRINDLE, S. D., & GREENGARD, P. (1971) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28988-1 · Cited by 388
Acute suppression of spontaneous neurotransmission drives synaptic potentiation
Nosyreva, E., Szabla, K., Autry, A. E., Ryazanov, A. G., Monteggia, L. M., & Kavalali, E. T. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4998-12.2013 · Cited by 283
Self-citationGideons, E. S., Kavalali, E. T., & Monteggia, L. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323920111 · Cited by 232
Self-citationAtasoy, D., Ertunc, M., Moulder, K. L., Blackwell, J., Chung, C., Su, J., & Kavalali, E. T. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2432-08.2008 · Cited by 200
Self-citationMoaddel, R., Abdrakhmanova, G., Kozak, J., Jozwiak, K., Toll, L., Jimenez, L., Rosenberg, A., Tran, T., Xiao, Y., Zarate, C. A., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.023 · Cited by 176
Memantine binding to a superficial site on NMDA receptors contributes to partial trapping
Kotermanski, S. E., Wood, J. T., & Johnson, J. W. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.176297 · Cited by 100
Cited by
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540
Self-citationAttenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519
Dendritic structural plasticity and neuropsychiatric disease
Forrest, M. P., Parnell, E., & Penzes, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.16 · Cited by 464
Metadata
- Authors
- Suzuki, K., Nosyreva, E., Hunt, K. W., Kavalali, E. T., & Monteggia, L. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Monteggia, Lisa M.
- Venue
- Nature
- Published
- 2017-06
- Volume
- 546
- Issue
- 7659
- Pages
- E1-E3
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2631673659
- Cited by
- 180
- References
- 13
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 10 · 2023: 11 · 2022: 18 · 2021: 22 · 2020: 21 · 2019: 23 · 2018: 36 · 2017: 15
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- ketamine metabolites, hydroxynorketamine, NMDA receptor, synaptic plasticity, antidepressant effects, depression, rapid antidepressant response, spontaneous neurotransmission, glutamate release, memantine, age dependence, intraperitoneal administration, synaptic potentiation, depression biomarkers, depression remission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of a ketamine metabolite on synaptic NMDAR function. https://app.cochat.ai/papers/10.1038/nature22084
- The paper
- Suzuki, K., Nosyreva, E., Hunt, K. W., Kavalali, E. T., & Monteggia, L. M. (2017). Effects of a ketamine metabolite on synaptic NMDAR function. Nature. https://doi.org/10.1038/nature22084
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.